全文获取类型
收费全文 | 481篇 |
免费 | 32篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 16篇 |
妇产科学 | 8篇 |
基础医学 | 75篇 |
口腔科学 | 5篇 |
临床医学 | 48篇 |
内科学 | 83篇 |
皮肤病学 | 8篇 |
神经病学 | 13篇 |
特种医学 | 10篇 |
外科学 | 73篇 |
综合类 | 12篇 |
预防医学 | 38篇 |
眼科学 | 29篇 |
药学 | 65篇 |
中国医学 | 10篇 |
肿瘤学 | 21篇 |
出版年
2024年 | 1篇 |
2023年 | 7篇 |
2022年 | 4篇 |
2021年 | 16篇 |
2020年 | 15篇 |
2019年 | 17篇 |
2018年 | 23篇 |
2017年 | 16篇 |
2016年 | 8篇 |
2015年 | 20篇 |
2014年 | 25篇 |
2013年 | 24篇 |
2012年 | 45篇 |
2011年 | 43篇 |
2010年 | 30篇 |
2009年 | 18篇 |
2008年 | 28篇 |
2007年 | 29篇 |
2006年 | 35篇 |
2005年 | 20篇 |
2004年 | 23篇 |
2003年 | 18篇 |
2002年 | 4篇 |
2001年 | 1篇 |
2000年 | 3篇 |
1999年 | 3篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1992年 | 4篇 |
1991年 | 4篇 |
1989年 | 7篇 |
1988年 | 5篇 |
1987年 | 6篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1982年 | 1篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有517条查询结果,搜索用时 15 毫秒
31.
Reza Meshkani Mohammad Taghikhani Bagher Larijani Yadollah Bahrami Shohreh Khatami Ehteram Khoshbin Amir Ghaemi Sedigheh Sadeghi Fatemeh Mirkhani Azam Molapour Khosrow Adeli 《Clinical chemistry and laboratory medicine》2007,45(4):477-482
BACKGROUND: The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene has been variably associated with insulin resistance, obesity and type 2 diabetes in several populations. However, this association has not been studied in Iranian subjects and we hypothesized that this variation might be associated with insulin resistance, type 2 diabetes and related metabolic traits in this population. METHODS: The Pro12Ala genotypes were determined by PCR-restriction fragment length polymorphism in 696 unrelated subjects including 412 non-diabetic controls and 284 type 2 diabetic patients. RESULTS: The frequency of the Ala allele was 9.4% and 5.9% in controls and type 2 diabetic subjects, respectively [adjusted odds ratio (OR) 0.457, p=0.005]. The Ala allele did not show a significant effect on anthropometric and biochemical parameters in the type 2 diabetic group, whereas in non-diabetic subjects, carriers of the Ala allele had significantly lower fasting insulin (p=0.007) and homeostasis model assessment of insulin resistance (HOMA-IR) (p=0.009) levels compared to Pro/Pro subjects. Multivariate logistic regression analysis showed that Pro12Ala polymorphism was an independent determinant of type 2 diabetes in this population. CONCLUSIONS: Our results for a sample of Iranian type 2 diabetes cases and controls provide evidence that the Pro/Ala genotype of the PPARgamma-2 gene is associated with insulin sensitivity and may also have protective role against type 2 diabetes. 相似文献
32.
33.
Zahra Aryan Negar Mahmoudi Ali Sheidaei Shahabeddin Rezaei Zohreh Mahmoudi Kimyia Gohari Nazila Rezaei Mohammad Javad Hajipour Arezou Dilmaghani-Marand Farideh Razi Mahdi Sabooni Farzad Kompani Alireza Delavari Bagher Larijani Farshad Farzadfar 《Journal of clinical lipidology》2018,12(6):1471-1481.e4
34.
Effects of levothyroxine suppressive therapy on bone mineral density in premenopausal women 总被引:2,自引:0,他引:2
Larijani B Gharibdoost F Pajouhi M Sadjadi A Aghakhani S Eshraghian R Akrami SM Maalouf G 《Journal of clinical pharmacy and therapeutics》2004,29(1):1-5
BACKGROUND: Levothyroxine (L-T4) is widely prescribed for treating thyroid disorders, but its effect on bone mineral density (BMD), is being debated. OBJECTIVES: We studied the effect of supraphysiologic doses of L-T4 on BMD in a group of premenopausal women. PATIENTS AND METHODS: We included 50 women (mean age=36.8 +/- 7.6 years) receiving L-T4 for at least 1 year for treating their benign cold thyroid nodules. Serum T3, T4, thyroid-stimulating hormone (TSH), parathyroid hormone (PTH), calcium, and phosphate and urine calcium and sodium levels of all patients were measured. Bone density at femoral neck and lumbar (L1-L4) regions was measured, using dual energy X-ray absorptiometry (DXA). RESULTS: No significant decrease was detected in the bone density of the subjects treated with L-T4 compared with the control group. CONCLUSION: L-T4 treatment for 1 year is not associated with increased risk of osteoporosis in premenopausal women but other potential adverse effects still need to be monitored in women receiving L-T4 especially long-term. 相似文献
35.
Inhibition of alfentanil metabolism by erythromycin 总被引:2,自引:0,他引:2
R R Bartkowski M E Goldberg G E Larijani T Boerner 《Clinical pharmacology and therapeutics》1989,46(1):99-102
To investigate a possible connection between erythromycin administration and reduced elimination of alfentanil, a controlled crossover study of alfentanil pharmacokinetics was undertaken. Six subjects were monitored for alfentanil plasma levels for 8 hours after alfentanil was administered. These measurements were obtained after a 0-, 1-, and 7-day course of erythromycin. Elimination half-life increased significantly (p less than 0.01) after 7 days from the control value of 84.0 +/- 8.2 minutes to 131.4 +/- 43.5 minutes. Clearance was decreased significantly (p less than 0.05) from 3.9 +/- 0.8 ml/kg/min to 2.9 +/- 1.2 ml/kg/min after 7 days. Values after 1 day were intermediate. Distribution volume did not change significantly. Subjects differed sharply in their sensitivity to erythromycin. Because of the interaction between erythromycin and alfentanil, we recommend that patients who are receiving erythromycin should be given alfentanil in reduced amounts or should avoid the drug completely. 相似文献
36.
37.
Marjan Delkhosh Effat Merghati Khoei Abbas Rahimi Foroushani Mohammad Bagher Gharavi 《Health care for women international》2019,40(2):213-237
Refugee women are at high risk of experiencing high level of Intimate Partner Violence (IPV) and its negative impacts. We conducted a cross-sectional population-based household survey with refugees in a settlement in the city of Semnan, Iran, from 2016 to 2017. Afghan refugee women (n?=?188) with ages between 15 and 49?years were recruited for the survey. Overall, about 79.8% of the participants reported to have experienced a form of IPV in the past 12?months. IPV exposure is associated with a negative reproductive health outcome. The high prevalence of IPV found among refugee women in the present research and its strong links with poor reproductive health outcomes, underline the urgent need for the development and testing of appropriate interventions in refugee settlements. 相似文献
38.
Pooneh Salari Sharif Mahsa Asalforoush Fatemeh Ameri Bagher Larijani Mohammad Abdollahi 《Age (Dordrecht, Netherlands)》2010,32(2):179-186
Recently, n-3 fatty acids are in the center of attention for their potent anti-inflammatory effects. Osteoporosis as a chronic
senile disease is associated with inflammation, and the role of inflammatory mediators has been demonstrated in recent years.
The beneficial effects of n-3 fatty acids on bone were proven in many animal studies, while to date, no conclusive data is
available in human. The aim of this study was to evaluate the impact of n-3 fatty acids on bone biomarkers in osteoporotic
postmenopausal women. Twenty-five osteoporotic postmenopausal women were recruited in the study and randomized in treatment
and control groups. The patients received 900 mg n-3 fatty acid capsules or placebo per day for 6 months. Serum levels of
osteocalcin, bone alkaline phosphatase (BALP), calcium, vitamin D, and parathormone and urine concentration of pyridinoline
(Pyd) were measured at baseline, second month, and sixth month in both groups. In the treatment group, compared with baseline,
at the second month, osteocalcin increased slightly; thereafter, it showed decrement trend until the end of the study. In
the control group, it decreased all over the study. None of these changes was significant. BALP showed nonsignificant decrease
from baseline over the time in both groups. Urine level of Pyd decreased significantly (P < 0.05) in the treatment group, while no significant change was seen in the control group. Serum calcium and vitamin D increased
in both groups; however, changes were not significant. No significant changes were seen in calcium clearance and parathormone.
In conclusion, n-3 fatty acids can decrease bone resorption; however, it could not affect bone formation significantly after
6 months treatment. Further investigations are recommended. 相似文献
39.
40.